Moving screening and prevention care more upstream can help make an impact by getting patients diagnosed with cancer earlier, said Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas.
Screening and prevention of cancer needs to be a collaborative effort between oncology practices and primary care providers, explained Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas.
Transcript
Is there a way for oncology practices to partner with primary care providers to put more focus on screening and prevention?
This is a big initiative that we want to work with in our HOPE Initiative, eventually. We're starting right at the door when the patient is diagnosed, coming into our practice. We know that we can only make so much of an impact when a patient is diagnosed with cancer, right? However they come to us, if it's stage IV, if it's stage III, if it's stage I; however they come. We know, obviously, it would be much better if we can prevent it from being a stage IV, stage III, and that comes from screening and education and wellness and behavioral health.
One of the things that we believe is that if we can get our model upstream into primary care, the best way we can do that is if we can provide it in some kind of payer model so that people are actually incentivized to be able to do things like screening and prevention care and get out there and provide health literacy. Get out into the neighborhoods… we can see it on a map, who is not getting out there to get screened. So, if we can provide it in some kind of model where it is an entire package of primary care with specialty involved, and everybody is making their impact and being incentivized for it; while it sounds like a nice thing to do, making sure everybody's getting screened and getting their chronic illnesses and cancers caught early, it also will have to show some kind of [return on investment], and it has to be good for business and we believe that it can be. We believe that that's what is part of a really true value-based model.
If everyone got on board, we know there's research already out there, there's tons of research that shows the earlier that you intervene in a person's life, the better the outcomes are. As a cancer care center, we know that our specialty is an incredibly expensive specialty, but we didn't start it that way. We’re doing the best we can in terms of treating it and trying to keep costs down. But, we think that—not that someone else should do it and only them—we think that as a group from beginning to the end, we can all have an impact there.
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More